Pernicious anemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Pernicious anemia Classification and external resources | |
| ICD-10 | D51.0 |
|---|---|
| ICD-9 | 281.0 |
| DiseasesDB | 9870 |
| MedlinePlus | 000569 |
| eMedicine | med/1799 |
| MeSH | D000752 |
|
WikiDoc Resources for Pernicious anemia | |
|
Articles | |
|---|---|
|
Most recent articles on Pernicious anemia Most cited articles on Pernicious anemia | |
|
Media | |
|
Powerpoint slides on Pernicious anemia | |
|
Evidence Based Medicine | |
|
Cochrane Collaboration on Pernicious anemia | |
|
Clinical Trials | |
|
Ongoing Trials on Pernicious anemia at Clinical Trials.gov Trial results on Pernicious anemia Clinical Trials on Pernicious anemia at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Pernicious anemia NICE Guidance on Pernicious anemia
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Pernicious anemia Discussion groups on Pernicious anemia Patient Handouts on Pernicious anemia Directions to Hospitals Treating Pernicious anemia Risk calculators and risk factors for Pernicious anemia
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Pernicious anemia | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Pernicious anemia (also known as Biermer's anaemia or Addison's anaemia or Addison-Biermer anaemia) is a form of megaloblastic anaemia due to vitamin B12 deficiency dependent on impaired absorption of vitamin B12 in the setting of atrophic gastritis, and more specifically of loss of gastric parietal cells. While the term "pernicious anaemia" is sometimes also incorrectly used to indicate megaloblastic anaemia due to any cause of vitamin B12 deficiency, its proper usage refers to that caused by atrophic gastritis and parietal cell loss only.
Mechanisms & manifestations
Pathophysiology
Vitamin B12 cannot be produced by the human body, and must therefore be obtained from diet. Normally, dietary vitamin B12 can only be absorbed by the ileum when it is bound by the intrinsic factor produced by parietal cells of the gastric mucosa. In pernicious anaemia, this process is impaired because of loss of parietal cells, resulting in insufficient absorption of the vitamin, which over a prolonged period of time ultimately leads to vitamin B12 deficiency and thus megaloblastic anaemia.
Presentation
The presentation of pernicious anaemia resembles that of any other form of anaemia, but is often accompanied by the manifestations of vitamin B12 deficiency (notably neurological abnormalities such as peripheral neuropathy), as well as by other manifestations of autoimmune atrophic gastritis.
Causes
Most commonly, the cause for impaired binding of vitamin B12 by intrinsic factor is autoimmune atrophic gastritis, in which autoantibodies are directed against parietal cells (resulting in their loss) as well as against the intrinsic factor itself (rendering it unable to bind vitamin B12). Less frequently, loss of parietal cells may simply be part of a widespread atrophic gastritis of non-autoimmune origin, such as that frequently occurring in elderly people affected with long-standing chronic gastritis of any cause (including Helicobacter pylori infection). Note that forms of vitamin B12 deficiency other than pernicious anaemia must be considered in the differential diagnosis of megaloblastic anaemia.
Diagnosis
A diagnosis of pernicious anaemia first requires demonstration of megaloblastic anaemia (through a full blood count) and of its direct cause, vitamin B12 deficiency (by measuring B12 levels in serum). A Schillings test can then be used to distinguish pernicious anemia from other causes of vitamin B12 deficiency (notably malabsorption. A diagnosis of atrophic gastritis should be confirmed by gastroscopy with biopsies. Approximately 90% of individuals with pernicious anemia have antibodies for parietal cells, however only 50% of individuals with these antibodies have pernicious anaemia.
Pathology
Treatment
Being a manifestation of vitamin B12 deficiency, pernicious anaemia is treated by administering vitamin B12 supplements. Note that if oral tablets are chosen for this purposes, much higher doses are given than normally required in order to overcome the impaired absorption that characterises pernicious anaemia. If oral tablets are not sufficient, vitamin B12 can also be administered via injection. Often the patient can learn to do this at home.
History
The treatment for pernicious anemia was first devised by George Whipple who bled dogs to make them anemic and then fed them various substances to see what (if anything) would make them healthy again. He discovered that ingesting large amounts of liver seemed to cure the disease. George Minot and William Murphy then set about to chemically isolate the curative substance and ultimately were able to isolate the vitamin B12 from the liver. For this, all three shared the 1934 Nobel Prize in Medicine. As a result, pernicious anemia is now treated with either vitamin B12 injections, or large oral doses of vitamin B12, typically between 2 and 4 mg daily.
Famous sufferers
- Inez Milholland, American Suffragette.
- Alexander Graham Bell, Scottish scientist and inventor.
- Annie Oakley.
- Norman Warne, Editor/Publisher & fiance of Beatrix Potter.
- Yoon Eun Hye, A South Korean actress
External links
- The Pernicious Anaemia Society, a UK-based charitable organisation which operates a forum where you can discuss Pernicious Anaemia with other sufferers around the world.
- Parietal cell antibody
- Antibody to GPC
WikiDoc Research Resources for Pernicious anemia | |
|---|---|
| Articles on Pernicious anemia | Most recent articles on Pernicious anemia • Most cited articles on Pernicious anemia • Review articles on Pernicious anemia • Articles on Pernicious anemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Pernicious anemia | Powerpoint slides on Pernicious anemia • Images of Pernicious anemia • Photos of Pernicious anemia • Podcasts & MP3s on Pernicious anemia • Videos on Pernicious anemia |
| Evidence Based Medicine Regarding Pernicious anemia | Cochrane Collaboration on Pernicious anemia • Bandolier on Pernicious anemia • TRIP on Pernicious anemia |
| Cost Effectiveness of Pernicious anemia | Cost Effectiveness of Pernicious anemia |
| Clinical Trials Involving Pernicious anemia | Ongoing Trials on Pernicious anemia at Clinical Trials.gov • Trial results on Pernicious anemia • Clinical Trials on Pernicious anemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Pernicious anemia | US National Guidelines Clearinghouse on Pernicious anemia • NICE Guidance on Pernicious anemia • NHS PRODIGY Guidance • FDA on Pernicious anemia • CDC on Pernicious anemia |
| Textbook Information on Pernicious anemia | Books and Textbook Information on Pernicious anemia |
| Pharmacology Resources on Pernicious anemia | Dosing of Pernicious anemia • Drug interactions with Pernicious anemia • Side effects of Pernicious anemia • Allergic reactions to Pernicious anemia • Overdose information on Pernicious anemia • Carcinogenicity information on Pernicious anemia • Pernicious anemia in pregnancy • Pharmacokinetics of Pernicious anemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Pernicious anemia | Genetics of Pernicious anemia • Pharmacogenomics of Pernicious anemia • Proteomics of Pernicious anemia |
| Newstories on Pernicious anemia | Pernicious anemia in the news • Be alerted to news on Pernicious anemia • News trends on Pernicious anemia |
| Commentary on Pernicious anemia | Blogs on Pernicious anemia |
| Patient Resources on Pernicious anemia | Patient resources on Pernicious anemia • Discussion groups on Pernicious anemia • Patient Handouts on Pernicious anemia • Directions to Hospitals Treating Pernicious anemia • Risk calculators and risk factors for Pernicious anemia |
| Healthcare Provider Resources on Pernicious anemia | Symptoms of Pernicious anemia • Causes & Risk Factors for Pernicious anemia • Diagnostic studies for Pernicious anemia • Treatment of Pernicious anemia |
| Continuing Medical Education (CME) Programs on Pernicious anemia | CME Programs on Pernicious anemia |
| International Resources on Pernicious anemia | Pernicious anemia en Espanol • Pernicious anemia en Francais |
| Business Resources on Pernicious anemia | Pernicious anemia in the Marketplace • Patents on Pernicious anemia |
| Informatics Resources on Pernicious anemia | List of terms related to Pernicious anemia |
nl:Pernicieuze anemiefi:Pernisiöösi anemia
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

